InsiderSignal.AI

InsiderSignal.ai

VRTX - Vertex Pharmaceuticals Inc / Ma

Insider Sale by Bozic Carmen (EVP, CMO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Bozic Carmen, serving as EVP, CMO at Vertex Pharmaceuticals Inc / Ma (VRTX), sold 2,329 shares at $450.95 per share, for a total transaction value of $1,050,263.00. Following this transaction, Bozic Carmen now holds 33,076 shares of VRTX.

This sale represents a 7.00% decrease in Bozic Carmen's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, March 27, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 31, 2026, 4 days after the trade was made.

Vertex Pharmaceuticals Inc / Ma operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Bozic Carmen

EVP, CMO

Carmen Bozic, M.D. is the Executive Vice President (EVP) and Chief Medical Officer (CMO) at Vertex Pharmaceuticals Inc. (VRTX).[[1]](https://www.fiercebiotech.com/biotech/vertex-bolsters-c-suite-new-cmo-chief-regulatory-officer)[[2]](https://www.sahmcapital.com/news/content/vertex-evp-and-cmo-carmen-bozic-disposes-of-common-shares-2026-03-04)[[3]](https://go.gale.com/ps/i.do?id=GALE%7CA602573705&sid=sitemap&v=2.1&it=r&p=HRCA&sw=w) She assumed the CMO role on April 1, 2020, succeeding Reshma Kewalramani, who advanced to CEO, while continuing her responsibilities as head of global medicines development and medical affairs.[[1]](https://www.fiercebiotech.com/biotech/vertex-bolsters-c-suite-new-cmo-chief-regulatory-officer)[[3]](https://go.gale.com/ps/i.do?id=GALE%7CA602573705&sid=sitemap&v=2.1&it=r&p=HRCA&sw=w) Bozic brings over 20 years of industry experience, starting her career at Biogen before joining Vertex, where she advanced from Senior Vice President of global clinical development to her current executive positions.[[1]](https://www.fiercebiotech.com/biotech/vertex-bolsters-c-suite-new-cmo-chief-regulatory-officer) At Vertex, she has contributed to advancing the company's cystic fibrosis portfolio and developing therapies for other serious diseases.[[1]](https://www.fiercebiotech.com/biotech/vertex-bolsters-c-suite-new-cmo-chief-regulatory-officer) Recently, as EVP and CMO, she disposed of common shares in the company.[[2]](https://www.sahmcapital.com/news/content/vertex-evp-and-cmo-carmen-bozic-disposes-of-common-shares-2026-03-04)

View full insider profile →

Trade Price

$450.95

Quantity

2,329

Total Value

$1,050,263.00

Shares Owned

33,076

Trade Date

Friday, March 27, 2026

9 days ago

SEC Filing Date

Tuesday, March 31, 2026

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Vertex Pharmaceuticals Inc / Ma

Company Overview

No company information available
View news mentioning VRTX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5254757

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime